Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01872078 · ClinicalTrials.gov registry record · Phase 2
A Study of AZD4901 in Females With Polycystic Ovary Syndrome
A Phase 2 study, sponsored by AstraZeneca.
- Completed
- Registry status
- Phase 2
- Development phase
- 67
- Enrollment target
NCT01872078: Completed Phase 2 study, sponsored by AstraZeneca.
NCT01872078 is a Phase 2 study that has completed, run by AstraZeneca. The registered enrollment target is 67 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (50% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01872078, a Phase 2 study, has completed, sponsored by AstraZeneca.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 67 participants
- Enrollment target
Study Summary
To assess the effects of AZD4901 when given in multiple doses to females with Polycystic Ovary Syndrome
Primary Outcome
Change-from-baseline of luteinising hormone area under the concentration-time curve from time zero to 8 hours postdose \[AUC(0-8)\] at Day 7
Interventions
- DRUG AZD4901 (oral)
- DRUG Placebo to match AZD4901
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 67 participants |
| Start Date | 2013-06 |
| Est. Completion | 2014-07 |
| Phase | Phase 2 |
What the finished NCT01872078 record still lists
NCT01872078 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 67 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (50% lower).
The record links to 0 conditions, and to 2 interventions - of which AZD4901 (oral) is the first listed.
NCT01872078 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01872078 about?
NCT01872078 is a clinical study titled "A Study of AZD4901 in Females With Polycystic Ovary Syndrome". To assess the effects of AZD4901 when given in multiple doses to females with Polycystic Ovary Syndrome
What is the current status of trial NCT01872078?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 67 participants. The study started on 2013-06. Estimated completion is 2014-07.
What interventions are being tested in trial NCT01872078?
The interventions under investigation include: AZD4901 (oral) (DRUG), Placebo to match AZD4901 (DRUG).
Who is sponsoring clinical trial NCT01872078?
This trial is sponsored by AstraZeneca, which has 1,285 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01872078's enrollment target sits among peer trials
67 974th of 2000 higher than 1,026 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03213002 · 67 participants · Phase 1
Oral Capecitabine and Temozolomide (CAPTEM) for Newly Diagnosed GBM
- NCT04115163 · 67 participants · Phase 2
Biologically Optimized Infusion Schedule of Gemcitabine and Nab-Paclitaxel for the Treatment of Metastatic Pancreatic Cancer
- NCT04315324 · 67 participants · Phase 1
Study to Test OBI-3424 in Patients With T-Cell Acute Lymphoblastic Leukemia (T-ALL) or T-Cell Lymphoblastic Lymphoma (T-LBL)
- NCT04532424 · 67 participants · NA
Transcranial Magnetic Stimulation for Restricted and Repetitive Behavior in ASD
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia